Abbott Laboratories (ABT) Research & Development (2016 - 2025)
Abbott Laboratories (ABT) has disclosed Research & Development for 17 consecutive years, with $735.0 million as the latest value for Q4 2025.
- Quarterly Research & Development fell 1.87% to $735.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 billion through Dec 2025, up 3.45% year-over-year, with the annual reading at $2.9 billion for FY2025, 3.45% up from the prior year.
- Research & Development hit $735.0 million in Q4 2025 for Abbott Laboratories, down from $766.0 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $782.0 million in Q3 2022 to a low of $654.0 million in Q1 2021.
- Historically, Research & Development has averaged $707.8 million across 5 years, with a median of $706.5 million in 2023.
- Biggest five-year swings in Research & Development: rose 16.37% in 2022 and later fell 14.07% in 2023.
- Year by year, Research & Development stood at $762.0 million in 2021, then decreased by 4.86% to $725.0 million in 2022, then fell by 3.45% to $700.0 million in 2023, then increased by 7.0% to $749.0 million in 2024, then fell by 1.87% to $735.0 million in 2025.
- Business Quant data shows Research & Development for ABT at $735.0 million in Q4 2025, $766.0 million in Q3 2025, and $725.0 million in Q2 2025.